((自动化翻译由路透提供，请见免责声明 ))
10月28日 - ** Vera Therapeutics公司 股价上涨14.1%至46.88美元，创4月份以来新高 ** 上周六，Vera公司报告了 (link)，该公司的肾病药物atacicept作为IgA肾病的一种潜在治疗方法的中期研究获得了更多数据。
** IgA肾病会导致一种名为免疫球蛋白A的蛋白质在肾脏中堆积。
** 在第 96 周，与安慰剂相比，阿帕西普有助于降低尿液中过量的蛋白质水平并稳定肾功能水平 - VERA ** VERA 表示，它将在 2025 年第二季度提交阿卡西普后期研究的 (link) 结果。
** 包括本交易日的走势在内，该公司股价在今年已上涨了两倍多
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.